NCT03266757已完成不适用
Observational Study of the Clinical Practice in Patients With Borderline Resectable or Resectable or Advanced Pancreatic Adenocarcinoma in Greece
Hellenic Society of Medical Oncology0 个研究点目标入组 200 人开始时间: 2016年2月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
- 主要终点
- clinical practice-treatments
研究概览
简要总结
Observational study of the Clinical Practice in patients with Borderline resectable or resectable or advanced pancreatic adenocarcinoma.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients Age 18 or older with histologically confirmed ductal pancreatic adenocarcinoma as a primary tumor
- •Patients with ductal pancreatic adenocarcinoma (Borderline resectable or resectable or advanced)
- •Patients that are alive and under treatment or follow up
- •Signed informed consent (ICF)
排除标准
- •Presence of other primary tumors
- •Pancreatic adenocarcinoma due to metastasis from other primary tumor(s)
- •Neuroendocrine or other pancreatic carcinoma other than ductal adenocarcinoma
- •Patients who refuse to provide informed consent
结局指标
主要结局
clinical practice-treatments
时间窗: 2 years
次要结局
- progression Free Survival(2 years)
- Overall Survival(2 years)
研究者
相似试验
招募中
不适用
A Study in Radiotherapy-related Nervous System ComplicationsNervous System ComplicationNCT03908502Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University4,000
Enrolling By Invitation
不适用
Perioperative Treatment Outcomes of Early NSCLCNSCLCNCT06610240Shanghai Chest Hospital500
已完成
不适用
Evaluation of Clinical Effectiveness of Roflumilast in Routine Practice, in Chronic Obstructive Pulmonary Disease (COPD) Patients in GreeceChronic Obstructive Pulmonary DiseaseNCT02187926AstraZeneca2,577
尚未招募
不适用
Clinical Characteristics and Outcome of Patients With Community Acquired PneumoniaCommunity Acquired Pneumonia (CAP)NCT06716099Sohag University100
已完成
不适用
Study to Assess Management and Outcomes of Hospitalised Patients With Complicated UTI (RESCUING)Urinary Tract InfectionsBacterial ResistanceNCT02641015Institut d'Investigació Biomèdica de Bellvitge1,028